Immunomedics (Germany)

Immunomedics (Germany)

Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Immunomedics (Germany), Germany, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

65%


Total
Publications

74


Total Open
Publications

48


Total
Citations

1.9K


Open Access
Percentage

65%


Total
Publications

74


Total Open
Publications

48


Total
Citations

1.9K

Wikipedia

Website

download

Breakdown

33% 31% 1% 35%

Publisher Open

33%

Both

31%

Other Platform Open

1%

Closed

35%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

012345678Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

46%OA Journal

OA Journal 46%

22

Hybrid 14%

7

No Guarantees 40%

19

Other Platform Open

Domain 75%

18

Institution 25%

6

Other Internet 21%

5

Preprint 0%

0

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
17
DOI
Other Internet
5
Unknown Repository
Other Internet
1
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
1
University of Dundee - Discovery Research Portal
Institution
1
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca
Institution
1
RISalud Institutional Health Repository of AndalucĂ­a
Institution
1
Fraunhofer-Gesellschaft - Fraunhofer-Publica
Institution
1
Europe PMC
Domain
1
Digital Access to Libraries
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share